Glucose monitoring for scheduled cesarean births
Part of Hormones & metabolism, Women’s health & pregnancy clinical trials.
This study tests whether wearing a continuous glucose monitor around the time of your scheduled cesarean helps keep blood sugar levels more stable. It may help understand and improve recovery and outcomes for mothers and babies.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are pregnant with one baby only (not twins or more).
- You have no history of diabetes, including diabetes during this pregnancy.
- You are between 18 and 50 years old.
- Your delivery is scheduled (not an emergency) in the Mount Sinai Health System.
- You do not have other hormone conditions that affect blood sugar and have not had steroid shots in the last two weeks before delivery.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study compares a continuous glucose monitor (CGM) to standard finger-prick testing for managing gestational diabetes. It aims to see if the CGM can improve blood sugar control and maternal outcomes.
This study tests whether using a continuous glucose monitor (a small sensor that checks your blood sugar all day) can improve outcomes for you and your baby during gestational diabetes. It may help you manage your blood sugar more easily and reduce risks.
This study tests a continuous glucose monitor (a small patch that tracks your blood sugar) for a few weeks after you give birth. It aims to see if this tool can help women who recently had gestational diabetes better understand their blood sugar levels after delivery.
This study uses a continuous glucose monitor (a small sensor that tracks your blood sugar) after you give birth to see if your blood sugar levels return to normal. It may help detect early signs of type 2 diabetes and guide your postpartum care.
This study compares using a continuous glucose monitor (a small sensor that tracks sugar levels all day) with the usual finger-prick testing in women with gestational diabetes. The goal is to see if the monitor helps control blood sugar better and is easier to use.
This study uses a continuous glucose monitor to track blood sugar for 2 weeks after delivery in women who had gestational diabetes. The goal is to better understand who develops type 2 diabetes later and help prevent it.
Hear when a new Dysglycemia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.